3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
35
Observational
2
Sponsor
Cancer Type
Gastrointestinal
5
Breast
4
Other hematologic neoplasm
2
Tumor-Agnostic
1
Thoracic
1
Other
1
Lymphoid
1
Genitourinary
1
Dermatologic
1
Conditions
Motor Activity
2
Pulmonary Disease, Chronic Obstructive
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms
1
Hematologic Neoplasms
1
Interventions
Flow Cytometry
36
Gene Expression Profiling
34
Surveys and Questionnaires
27
Polymerase Chain Reaction
24
Microarray Analysis
23
Blood Specimen Collection
19
Interviews as Topic
18
Imatinib Mesylate
15
Amplified Fragment Length Polymorphism Analysis
14
Reverse Transcriptase Polymerase Chain Reaction
13
Cytogenetic Analysis
13
Rituximab
12
venetoclax
11
nilotinib
10
Psychiatric Rehabilitation
10
Dasatinib
10
Immunologic Techniques
9
DNA Methylation
9
Blotting, Western
9
ponatinib
8
Observation
8
In Situ Hybridization, Fluorescence
8
Base Sequence
8
Azacitidine
8
ibrutinib
7
fludarabine
7
bosutinib
7
Watchful Waiting
7
Therapeutics
7
Specimen Handling
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
Exercise
×
Other hematologic neoplasm
×
Clear all
NCT05025774
2025-11-24
FLASHLITE
Masonic Cancer Center, University of Minnesota
Recruiting
90 enrolled
NCT06102876
2025-04-10
ACCES
University Hospital, Toulouse
Active not recruiting
69 enrolled